0001437749-20-021899.txt : 20201029 0001437749-20-021899.hdr.sgml : 20201029 20201029070702 ACCESSION NUMBER: 0001437749-20-021899 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20201029 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20201029 DATE AS OF CHANGE: 20201029 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ULTRALIFE CORP CENTRAL INDEX KEY: 0000875657 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690] IRS NUMBER: 161387013 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-20852 FILM NUMBER: 201270460 BUSINESS ADDRESS: STREET 1: 2000 TECHNOLOGY PARKWAY CITY: NEWARK STATE: NY ZIP: 14513 BUSINESS PHONE: 3153327100 MAIL ADDRESS: STREET 1: 2000 TECHNOLOGY PARKWAY CITY: NEWARK STATE: NY ZIP: 14513 FORMER COMPANY: FORMER CONFORMED NAME: ULTRALIFE BATTERIES INC DATE OF NAME CHANGE: 19940224 8-K 1 ulbi20201028_8k.htm FORM 8-K ulbi20201028_8k.htm
false 0000875657 0000875657 2020-10-29 2020-10-29
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
 
October 29, 2020
Date of Report (Date of Earliest Event Reported)
 
 
ULTRALIFE CORPORATION
(Exact name of registrant as specified in its charter)
 
Delaware
000-20852
16-1387013
(State of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
 
2000 Technology Parkway, Newark, New York 14513
(Address of principal executive offices) (Zip Code)
 
(315) 332-7100
(Registrant’s telephone number, including area code)
 
None
(Former name or former address, if changed since last report)
 
Securities registered pursuant to Section 12(b) of the Act:
 
Common Stock, $0.10 par value per share
ULBI
NASDAQ
(Title of each class)
(Trading Symbol)
(Name of each exchange on which registered)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging Growth Company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
Item 2.02 Results of Operations and Financial Condition
 
On October 29, 2020, Ultralife Corporation issued a press release regarding the financial results for its third quarter ended September 30, 2020. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by this reference.
 
The information set forth in this Form 8-K and the attached exhibit is being furnished to and not filed with the Securities and Exchange Commission and shall not be deemed as incorporated by reference in any filing under the Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as amended, except to the extent specifically provided in any such filing.
 
 
Item 9.01 Financial Statements, Pro Forma Financials and Exhibits
 
(d) Exhibits.
 
Exhibit
Number
 
Exhibit Description
 
99.1
   
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)  
 
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: October 29, 2020
 
ULTRALIFE Corporation
     
     
 
By:
/s/ Philip A. Fain
   
Philip A. Fain
   
Chief Financial Officer and Treasurer
     
     
 
 
EX-99.1 2 ex_209556.htm EXHIBIT 99.1 ex_209556.htm

Exhibit 99.1

ex_209556img001.jpg

 

 

Ultralife Corporation Reports Third Quarter Results

 

NEWARK, N.Y. – October 29, 2020 -- Ultralife Corporation (NASDAQ: ULBI) reported operating income of $0.7 million on revenue of $24.4 million for the third quarter ended September 30, 2020. For the third quarter of 2019, the Company reported operating income of $1.3 million on revenue of $27.5 million.

 

“Effective execution of both our end-market diversification strategy and operating discipline during the third quarter sustained profitability and positive cash flows, despite a reduction in total Company results largely due to the continuing global economic impact of the pandemic,” said Michael D. Popielec, President and Chief Executive Officer. “Within Battery & Energy Products, we posted record quarterly medical sales which increased 102% over last year, and a 23% increase in government/defense sales. These strong gains were offset by economic weakness in the oil and gas sector and lower sales for our Communications Systems business. In response, we continued our spending control, matching the overall percentage decline in our revenue with a comparable reduction in operating expenses. By preserving profitability and continuing to improve working capital management, during the quarter we also further reduced debt by $7.1 million. Supported by a solid balance sheet and resilient business model, we are committed to completing our strategic growth projects and are well positioned to withstand current economic headwinds.”

 

 

Third Quarter 2020 Financial Results

 

Revenue was $24.4 million, a decrease of $3.1 million, or 11.4%, compared to $27.5 million for the third quarter of 2019, as a 22.2% increase in core battery sales across diversified end-markets was offset by lower oil & gas market and Communications Systems sales. Total Company commercial sales decreased 10.8% and government/defense sales decreased 12.5% from the 2019 period. Battery & Energy Products revenues declined 3.4% to $21.8 million, compared to $22.6 million last year, as a 102.1% increase in medical battery sales, especially those used in ventilators, respirators and infusion pumps, and a 23.4% increase in government/defense sales, were offset by a 68.7% decline in oil & gas market sales. Communications Systems sales decreased 48.3% to $2.5 million compared to $4.9 million for the same period last year, primarily reflecting 2019 shipments of vehicle amplifier-adaptor systems to support the U.S. Army’s Network Modernization initiatives under the delivery orders announced in October 2018. These orders were completed in the second quarter of 2020. The net adverse impact of COVID-19 on revenues for the 2020 period was approximately $2.9 million as a substantial increase in demand for medical batteries was more than offset by weakened demand in the oil & gas and international industrial markets. Logistics disruptions also delayed certain shipments.

 

Gross profit was $6.5 million, or 26.7% of revenue, compared to $7.9 million, or 28.6% of revenue, for the same quarter a year ago. Battery & Energy Products’ gross margin was 26.0%, compared to 27.1% last year, primarily due to the mix impact of lower oil & gas market sales in 2020. Communications Systems gross margin was 32.8%, compared to 35.5% last year, due to lower factory throughput in 2020 and sales mix.

 

 

 

Operating expenses were $5.8 million compared to $6.6 million last year, a reduction of 11.5%. Operating expenses were 23.8% of revenue equal to that of the year-earlier period.

 

Operating income was $0.7 million compared to $1.3 million last year, and operating margin was 2.9% compared to 4.8% last year. The net adverse impact of COVID-19 on operating income for the 2020 period was approximately $1.0 million.

 

Net income was $0.4 million or $0.03 per diluted share on a GAAP basis using the U.S. statutory tax rate, compared to net income of $0.9 million, or $0.06 per diluted share for the third quarter of 2019. Adjusted EPS was $0.04 on a diluted basis for the third quarter of 2020, compared to $0.07 for the 2019 period. Adjusted EPS excludes the provision for deferred taxes which primarily represents non-cash charges of $0.2 million for U.S. taxes which will be fully offset by net operating loss carryforwards and other tax credits for the foreseeable future. The net adverse impact of COVID-19 on Adjusted EPS for the 2020 period was approximately $0.06.

 

Adjusted EBITDA, defined as EBITDA including non-cash, stock-based compensation expense, for the trailing twelve-month period was $10.9 million or 9.9% of sales.

 

During the third quarter of 2020, the Company continued its strong working capital management reducing the debt related to the May 2019 acquisition of Southwest Electronic Energy Corporation by $7.1 million, or 64.6%, to $3.9 million while increasing its cash on hand by $5.4 million, or 64.2%, to $13.8 million.

 

See the “Non-GAAP Financial Measures” section of this release for a reconciliation of Adjusted EPS to EPS and Adjusted EBITDA to Net Income Attributable to Ultralife Corporation.

 

 

 

About Ultralife Corporation

 

Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.

 

Headquartered in Newark, New York, the Company's business segments include Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit www.ultralifecorporation.com.

 

 

 

Conference Call Information

 

Ultralife will hold its third quarter earnings conference call today at 8:30 AM ET. To participate in the live call, please dial (800) 915-4836 at least ten minutes before the scheduled start time, identify yourself and ask for the Ultralife call. A live webcast of the conference call will be available to investors in the Events & Presentations section of the Company's website at http://investor.ultralifecorporation.com. For those who cannot listen to the live broadcast, a replay of the webcast will be available shortly after the call at the same location.

 

This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include potential reductions in revenues from key customers, acceptance of our new products on a global basis and uncertain global economic conditions. The Company cautions investors not to place undue reliance on forward-looking statements, which reflect the Company's analysis only as of today's date. The Company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances. Further information on these factors and other factors that could affect Ultralife’s financial results is included in Ultralife’s Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K.

 

 

 

ULTRALIFE CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Dollars in Thousands)

(Unaudited)

                 

ASSETS

                 

 

   

September 30,

2020

   

December 31,

2019

 

Current Assets:

               

Cash

  $ 13,777     $ 7,405  

Trade Accounts Receivable, Net

    15,012       30,106  

Inventories, Net

    29,746       29,759  

Prepaid Expenses and Other Current Assets

    3,661       3,103  

Total Current Assets

    62,196       70,373  
                 

Property, Equipment and Improvements, Net

    22,605       22,525  

Goodwill

    26,705       26,753  

Other Intangible Assets, Net

    9,212       9,721  

Deferred Income Taxes, Net

    12,425       13,222  

Other Non-Current Assets

    2,411       1,963  

Total Assets

  $ 135,554     $ 144,557  
                 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

Current Liabilities:

               

Accounts Payable

  $ 8,875     $ 9,388  

Current Portion of Long-Term Debt

    1,537       1,372  

Accrued Compensation and Related Benefits

    1,258       1,655  

Accrued Expenses and Other Current Liabilities

    5,702       4,775  

Total Current Liabilities

    17,372       17,190  

Long-Term Debt

    2,190       15,780  

Deferred Income Taxes

    480       559  

Other Non-Current Liabilities

    1,675       1,278  

Total Liabilities

    21,717       34,807  
                 

Shareholders' Equity:

               

Common Stock

    2,033       2,026  

Capital in Excess of Par Value

    185,261       184,292  

Accumulated Deficit

    (49,706 )     (52,830 )

Accumulated Other Comprehensive Loss

    (2,619 )     (2,531 )

Treasury Stock

    (21,246 )     (21,231 )

Total Ultralife Equity

    113,723       109,726  

Non-Controlling Interest

    114       24  

Total Shareholders’ Equity

    113,837       109,750  
                 

Total Liabilities and Shareholders' Equity

  $ 135,554     $ 144,557  

 

 

 

ULTRALIFE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(In Thousands Except Per Share Amounts)

(Unaudited)

 

 

   

Three-Month Period Ended

   

Nine-Month Period Ended

 
   

September

30,

   

September

29,

   

September

30,

   

September

29,

 
   

2020

   

2019

   

2020

   

2019

 

Revenues:

                               

Battery & Energy Products

  $ 21,819     $ 22,578     $ 66,616     $ 58,876  

Communications Systems

    2,543       4,915       12,120       16,896  

Total Revenues

    24,362       27,493       78,736       75,772  
                                 

Cost of Products Sold:

                               

Battery & Energy Products

    16,142       16,461       49,597       42,694  

Communications Systems

    1,709       3,171       7,331       11,268  

Total Cost of Products Sold

    17,851       19,632       56,928       53,962  
                                 

Gross Profit

    6,511       7,861       21,808       21,810  
                                 

Operating Expenses:

                               

Research and Development

    1,606       2,029       4,429       4,652  

Selling, General and Administrative

    4,198       4,526       12,893       12,262  

Total Operating Expenses

    5,804       6,555       17,322       16,914  
                                 

Operating Income

    707       1,306       4,486       4,896  
                                 

Other Expense

    53       160       262       301  

Income Before Income Tax Provision

    654       1,146       4,224       4,595  
                                 

Income Tax Provision

    192       225       1,010       942  
                                 

Net Income

    462       921       3,214       3,653  
                                 

Net Income Attributable to Non-Controlling Interest

    55       23       90       74  
                                 

Net Income Attributable to Ultralife Corporation

  $ 407     $ 898     $ 3,124     $ 3,579  
                                 
                                 

Net Income Per Share Attributable to Ultralife Common Shareholders – Basic

  $ .03     $ .06     $ .20     $ .23  
                                 

Net Income Per Share Attributable to Ultralife Common Shareholders – Diluted

  $ .03     $ .06     $ .19     $ .22  
                                 

Weighted Average Shares Outstanding – Basic

    15,908       15,785       15,889       15,756  
                                 

Weighted Average Shares Outstanding – Diluted

    16,089       16,162       16,103       16,138  

 

 

 

Non-GAAP Financial Measures:

 

Adjusted Earnings Per Share

 

In evaluating our business, we consider and use Adjusted EPS, a non-GAAP financial measure, as a supplemental measure of our business performance. We define Adjusted EPS as net income attributable to Ultralife Corporation excluding the provision for deferred taxes divided by our weighted average shares outstanding on both a basic and diluted basis. We believe that this information is useful in providing period-to-period comparisons of our results by reflecting the portion of our tax provision that will be offset by our U.S. net operating loss carryforwards and other tax credits for the foreseeable future. We reconcile Adjusted EPS to EPS, the most comparable financial measure under U.S. Generally Accepted Accounting Principles (“U.S. GAAP”). Neither current nor potential investors in our securities should rely on Adjusted EPS as a substitute for any GAAP measures and we encourage investors to review the following reconciliation of Adjusted EPS to EPS and net income attributable to Ultralife.

 

 

ULTRALIFE CORPORATION AND SUBSIDIARIES

CALCULATION OF ADJUSTED EPS

(In Thousands Except Per Share Amounts)

(Unaudited)

 

 

   

Three-Month Period Ended

 
   

September 30, 2020

   

September 29, 2019

 
   

Amount

   

Per Basic Share

   

Per Diluted Share

   

Amount

   

Per Basic Share

   

Per Diluted Share

 

Net Income

  $ 407     $ .03     $ .03     $ 898     $ .06     $ .06  

Deferred Tax Provision

    188       .01       .01       165       .01       .01  

Adjusted Net Income

  $ 595     $ .04     $ .04     $ 1,063     $ .07     $ .07  
                                                 

Weighted Average Shares Outstanding

            15,908       16,089               15,785       16,162  

 

 

   

Nine-Month Period Ended

 
   

September 30, 2020

   

September 29, 2019

 
   

Amount

   

Per Basic Share

   

Per Diluted Share

   

Amount

   

Per Basic Share

   

Per Diluted Share

 

Net Income

  $ 3,124     $ .20     $ .19     $ 3,579     $ .23     $ .22  

Deferred Tax Provision

    821       .05       .05       801       .05       .05  

Adjusted Net Income

  $ 3,945     $ .25     $ .24     $ 4,380     $ .28     $ .27  
                                                 

Weighted Average Shares Outstanding

            15,889       16,103               15,756       16,138  

 

 

 

Adjusted EBITDA

 

In evaluating our business, we consider and use Adjusted EBITDA, a non-GAAP financial measure, as a supplemental measure of our operating performance. We define Adjusted EBITDA as net income attributable to Ultralife Corporation before net interest expense, provision (benefit) for income taxes, depreciation and amortization, and stock-based compensation expense, plus/minus expenses/income that we do not consider reflective of our ongoing operations. We reconcile Adjusted EBITDA to net income attributable to Ultralife Corporation, the most comparable financial measure under U.S. GAAP. Neither current nor potential investors in our securities should rely on Adjusted EBITDA as a substitute for any GAAP measures and we encourage investors to review the following reconciliation of Adjusted EBITDA to net income attributable to Ultralife.

 

 

ULTRALIFE CORPORATION AND SUBSIDIARIES

CALCULATION OF ADJUSTED EBITDA

(Dollars in Thousands)

(Unaudited)

 

 

   

Three-Month Period Ended

   

Nine-Month Period Ended

 
   

September 30, 2020

   

September 29, 2019

   

September 30, 2020

   

September 29, 2019

 
                                 

Net Income Attributable to Ultralife Corporation

  $ 407     $ 898     $ 3,124     $ 3,579  

Adjustments:

                               

Interest and Financing Expense, Net

    92       220       372       339  

Income Tax Provision

    192       225       1,010       942  

Depreciation Expense

    582       586       1,743       1,548  

Amortization of Intangible Assets and Financing Fees

    161       160       480       404  

Stock-Based Compensation Expense

    222       159       756       519  

Non-Cash Purchase Accounting Adjustments

    -       59       -       264  

Adjusted EBITDA

  $ 1,656     $ 2,307     $ 7,485     $ 7,595  

 

 

 

Company Contact:

Ultralife Corporation

Philip A. Fain

(315) 210-6110

pfain@ulbi.com

 

Investor Relations Contact:

 

LHA

 

Jody Burfening

 

(212) 838-3777

 

jburfening@lhai.com

 
EX-101.SCH 3 ulbi-20201029.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 4 ulbi-20201029_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 ulbi-20201029_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] Document, Type Document, Period End Date Entity, Registrant Name Entity, Incorporation, State or Country Code Entity, File Number Entity, Tax Identification Number Entity, Address, Address Line One Entity, Address, City or Town Entity, Address, State or Province Entity, Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Entity, Emerging Growth Company Amendment Flag Entity, Central Index Key EX-101.PRE 6 ulbi-20201029_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 7 ex_209556img001.jpg begin 644 ex_209556img001.jpg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v3.20.2
Document And Entity Information
Oct. 29, 2020
Document Information [Line Items]  
Entity, Registrant Name ULTRALIFE CORPORATION
Document, Type 8-K
Document, Period End Date Oct. 29, 2020
Entity, Incorporation, State or Country Code DE
Entity, File Number 000-20852
Entity, Tax Identification Number 16-1387013
Entity, Address, Address Line One 2000 Technology Parkway
Entity, Address, City or Town Newark
Entity, Address, State or Province NY
Entity, Address, Postal Zip Code 14513
City Area Code 315
Local Phone Number 332-7100
Title of 12(b) Security Common Stock
Trading Symbol ULBI
Security Exchange Name NASDAQ
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity, Emerging Growth Company false
Amendment Flag false
Entity, Central Index Key 0000875657
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 1 95 1 false 0 0 false 0 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.ulbi.com/20201029/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports ulbi20201028_8k.htm ex_209556.htm ulbi-20201029.xsd ulbi-20201029_def.xml ulbi-20201029_lab.xml ulbi-20201029_pre.xml http://xbrl.sec.gov/dei/2020-01-31 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ulbi20201028_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "local": [ "ulbi-20201029_def.xml" ] }, "inline": { "local": [ "ulbi20201028_8k.htm" ] }, "labelLink": { "local": [ "ulbi-20201029_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "ulbi-20201029_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "ulbi-20201029.xsd" ], "remote": [ "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd" ] } }, "elementCount": 26, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ulbi", "nsuri": "http://www.ulbi.com/20201029", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "ulbi20201028_8k.htm", "contextRef": "d20208K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "role": "http://www.ulbi.com/20201029/role/statement-document-and-entity-information", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "tbody", "table", "body", "html" ], "baseRef": "ulbi20201028_8k.htm", "contextRef": "d20208K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document, Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document, Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity, Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity, Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity, Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity, Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity, Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity, Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity, File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity, Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity, Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity, Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.ulbi.com/20201029/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 16 0001437749-20-021899-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-20-021899-xbrl.zip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end